Krazati Faces Rejection in Europe
Mirati’s KRAS Inhibitor Krazati Faces Rejection in Europe
SG Tylor
Source – Mirati Therapeutics Mirati Therapeutics has faced a setback in its quest to market its lead KRAS inhibitor Krazati, ...
Source – Mirati Therapeutics Mirati Therapeutics has faced a setback in its quest to market its lead KRAS inhibitor Krazati, ...